Regulation of T cell activation and tolerance by Grail
Regulation of T cell activation and tolerance by Grail
批准号:
7869435
负责人:
Roza Insafetdinovna Nurieva
金额:
$38.12万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-15 至 2014-05-31
关键词:
Antigen-Presenting CellsAutoimmune DiseasesAutoimmune ResponsesAutoimmunityCD28 geneCD4 Positive T LymphocytesCell physiologyCellsDefectDevelopmentDown-RegulationEnsureGenerationsGenesHandIn VitroInterleukin-17InvadedKnockout MiceKnowledgeLeadLymphocyteLymphocyte ActivationModelingPeripheralPredispositionRegulationRegulatory T-LymphocyteRoleSignal TransductionT cell anergyT cell regulationT-Cell ActivationT-LymphocyteTissuesTransducersX Chromosomeabstractinganergyextracellularimmune functionimmune self tolerancein vivoinsightmutant mouse modelnovelpathogenperipheral tolerancepublic health relevancetranscription factorubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Abstract T lymphocyte activation is tightly regulated to ensure effective elimination of invading pathogens as well as maintaining tolerance against self-tissues. On one hand, T cells are regulated by extracellular signals, especially the positive and negative costimulatory molecules on antigen-presenting cells, and on the other hand, also by delicate intracellular signal transducers and regulators. Recently, we found that T cells activated in the absence of both CD28 and ICOS costimulation became nonfunctional and nonresponsive, supporting a critical role of costimulation in T cell activation. These tolerant T cells not only were anergic with profound defects in TCR signal transduction but also completely lacked expression of effector-specific transcription factors. Interestingly, expression of Grail (gene related to anergy in lymphocytes), was only upregulated in T cells when both CD28 and ICOS signaling were absent. Grail is an E3 ubiquitin ligase whose expression was previously found to be associated with CD4 T cell anergy in vitro and in vivo. Blocking of negative costimulatory signals (B7S1, B7-H3 or PD-1) restored T cell function, associated with expression of effector-specific transcription factors and down-regulation of Grail expression. To determine the function of Grail in T cell activation and tolerance, we developed a Grail mutant mouse model. We found that Grail-deficient T cells were not dependent on CD28 and ICOS signaling in activation and effector differentiation in vitro. Our central hypothesis for the current study is that Grail molecule critically regulates T cell tolerance and function. We will first analyze the role of Grail in peripheral T cell tolerance. In addition, we will determine the mechanisms whereby Grail regulates T cell tolerance. Secondly, we will analyze the function of Grail in generation and function of natural and inducible Treg cells. Lastly, we will assess whether Grail deficiency will lead to susceptibility to autoimmune diseases and whether this is caused by defects in na¿ve and/or Treg cells. These proposed studies will greatly advance our knowledge on Grail function in peripheral tolerance and autoimmune responses.
PUBLIC HEALTH RELEVANCE: T lymphocyte activation is tightly regulated to ensure effective elimination of invading pathogens as well as maintaining tolerance against self-tissues. On one hand, T cells are regulated by extracellular signals, especially the positive and negative costimulatory molecules on antigen-presenting cells, and on the other hand, also by delicate intracellular signal transducers and regulators. Our preliminary analysis of a Grail knockout mouse revealed its essential function in induction of T cell tolerance in vitro. In this project, we propose to continue our analysis on function of Grail in T cells in vitro and in vivo. These proposed studies will greatly advance our knowledge on Grail function in T cells and will provide a novel and unique insight into proper T cell regulation that governs self tolerance and immune function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors
-
批准号:10753628
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2023
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance
-
批准号:10311074
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2019
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Role of Cul4A in Governing Th2-Type Tolerance
-
批准号:10198025
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2018
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Role of Cul4A in Governing Th2-Type Tolerance
-
批准号:9770641
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2018
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Grail-targeting breaks the immune tolerance to melanoma
-
批准号:9379209
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2017
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
STAT1: New regulator of inflammatory Th17 and Th2 cells
-
批准号:9112386
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2016
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
STAT1: New regulator of inflammatory Th17 and Th2 cells
-
批准号:9206467
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2016
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Role of Grail in maintaining humoral immune tolerance
-
批准号:9089880
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2015
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Regulation of T cell activation and tolerance by Grail
-
批准号:8468985
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2009
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Regulation of T cell activation and tolerance by Grail
-
批准号:7700519
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2009
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Regulation of T cell activation and tolerance by Grail
-
批准号:8068904
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2009
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Regulation of T cell activation and tolerance by Grail
-
批准号:8277281
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2009
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: